6 – 10 of 103
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
(
- Contribution to journal › Article
-
Mark
At the Epicentre of COVID-19 - the Tragic Failure of the Global Supply Chain for Medical Supplies
2020) In Frontiers in Public Health(
- Contribution to journal › Article
-
Mark
Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield
(
- Contribution to journal › Article
-
Mark
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways
(
- Contribution to journal › Article
-
Mark
ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19
(
- Contribution to journal › Article